Allurion Technologies Inc. ALUR

Company Overview

Allurion Technologies Inc. is a medical device company focused on non-surgical weight loss and metabolic health solutions. The company operates within the medical devices and digital health industries, with a primary emphasis on obesity management. Its core offering is the Allurion Balloon, a swallowable, procedure-less gastric balloon designed to aid weight loss without surgery or endoscopy, combined with a digitally enabled behavior-change platform.

The company’s primary revenue drivers are sales of the Allurion Balloon Program, which integrates the balloon, remote patient monitoring, artificial intelligence–driven coaching, and clinical support tools for healthcare providers. Allurion serves physicians, weight-loss clinics, and hospitals, with patients as the ultimate end users. Its strategic differentiation lies in offering a fully non-invasive, endoscopy-free solution supported by proprietary digital monitoring and data analytics. Founded in 2009 and originally known as Elira Pharmaceuticals, the company rebranded as Allurion Technologies and expanded internationally before becoming publicly listed in 2023 following a business combination transaction.